PMI U.S. Expands ZYN Nicotine Pouch Lineup, Adds ULTRA Line
Stamford, Conn. – September 15, 2026 -- Philip Morris International's U.S. businesses (PMI U.S.) are expanding the ZYN nicotine pouch portfolio with new strengths and a moist pouch format, building on regulatory clearances secured earlier this year.
PMI U.S. adds 1.5 mg and 8 mg strengths to flagship ZYN dry pouch line
The flagship ZYN dry pouch lineup, previously available in 3 mg and 6 mg strengths, now includes 1.5 mg and 8 mg options across flavors such as Cool Mint, Wintergreen, Citrus, and Dragonberry, among others.
FDA authorizes 11 ZYN ULTRA products in August 2026
The U.S. Food and Drug Administration issued marketing granted orders in August 2026 for 11 ZYN ULTRA products, comprising ten 9 mg strengths and one 11 mg strength. ZYN ULTRA is a moist oral nicotine pouch positioned as a differentiated option for adults who smoke or use traditional oral tobacco products.